Implementation of Electronic Adherence Monitors and Associated Interventions for Routine HIV Antiretroviral Therapy in Uganda: Promising Findings

Jessica E Haberer, Robert Baijuka, John Bosco Tumuhairwe, Edna B Tindimwebwa, James Tinkamanyire, Ellyk Tuhanamagyezi, Lawrence Musoke, Lindsey E Garrison, Marisa DelSignore, Nicholas Musinguzi, Stephen Asiimwe, Jessica E Haberer, Robert Baijuka, John Bosco Tumuhairwe, Edna B Tindimwebwa, James Tinkamanyire, Ellyk Tuhanamagyezi, Lawrence Musoke, Lindsey E Garrison, Marisa DelSignore, Nicholas Musinguzi, Stephen Asiimwe

Abstract

Background: High, sustained adherence is critical for achieving the individual and public health benefits of HIV antiretroviral therapy (ART). Electronic monitors provide detailed adherence information and can enable real-time interventions; however, their use to date has largely been confined to research. This pilot study (NCT03825952) sought to understand feasibility and acceptability a relatively low-cost version of this technology and associated interventions for routine ART delivery in sub-Saharan Africa.

Methods: We provided two ART clinics in rural, southwestern Uganda with electronic adherence monitors for data-informed counseling as well as optional SMS messages to clients and/or social supporters (daily or triggered by missed or delayed doses) and/or an alarm. Clinic and ART client experiences were observed for 3 months per client, including time and motion studies. Qualitative interviews among clients, clinicians, and healthcare administrators were informed by the Consolidated Framework for Implementation Research.

Results: Fifty-one ART clients were enrolled; 57% were male and the median age was 34 years. Choice of associated intervention varied among participants. The median number of visits during follow-up was two per client. Counselors reviewed the adherence data with 90% of clients at least once; 67% reviewed data at all visits. Average adherence was 94%; four clients had adherence gaps >1 week. Acceptability was high; all but one client found the monitor "very useful" and all found SMS "very useful." Clinic visits among clients with the intervention lasted 4 min longer on average than those in standard care. The monitors and daily SMS generally functioned well, although excess SMS were triggered, primarily due to cellular network delays. Overall, participants felt the technology improved adherence, clinic experiences, and clinician-client relationships. Few worried about stigma and privacy. Cost was a concern for implementation, particularly at scale.

Conclusion: We successfully implemented a relatively low-cost electronic ART adherence monitor and associated interventions for routine care in rural Uganda. Feasibility and acceptability were generally high, and individuals were identified who could benefit from adherence support. Future work should involve longitudinal follow-up of diverse populations, clinical outcomes, and detailed cost-effectiveness analysis to help drive policy decisions around the uptake of this technology for routine clinical care.

Clinical trial registration: identifier: NCT03825952.

Keywords: Africa; HIV; SMS intervention; electronic adherence monitoring; implementation science.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Haberer, Baijuka, Tumuhairwe, Tindimwebwa, Tinkamanyire, Tuhanamagyezi, Musoke, Garrison, DelSignore, Musinguzi and Asiimwe.

Figures

Figure 1
Figure 1
The evriMED monitor and associated interventions. *SMS may be scheduled or triggered by a delayed or missed dose; they may also involve 1- or 2-way communication.

References

    1. Conway B. The role of adherence to antiretroviral therapy in the management of HIV infection. J Acquir Immune Defic Syndr. (2007) 45(Suppl. 1):S14–8. 10.1097/QAI.0b013e3180600766
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. . Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. (2011) 365:493–505. 10.1056/NEJMoa1105243
    1. Kagee A, Nel A. Assessing the association between self-report items for HIV pill adherence and biological measures. AIDS Care. (2012) 24:1448–52. 10.1080/09540121.2012.687816
    1. Okatch H, Beiter K, Eby J, Chapman J, Marukutira T, Tshume O, et al. . Brief report: apparent antiretroviral overadherence by pill count is associated with HIV treatment failure in adolescents. J Acquir Immune Defic Syndr. (2016) 72:542–5. 10.1097/QAI.0000000000000994
    1. Sangeda RZ, Mosha F, Prosperi M, Aboud S, Vercauteren J, Camacho RJ, et al. . Pharmacy refill adherence outperforms self-reported methods in predicting HIV therapy outcome in resource-limited settings. BMC Public Health. (2014) 14:1035. 10.1186/1471-2458-14-1035
    1. Spinelli MA, Haberer JE, Chai PR, Castillo-Mancilla J, Anderson PL, Gandhi M. Approaches to objectively measure antiretroviral medication adherence and drive adherence interventions. Curr HIV/AIDS Rep. (2020) 17:301–14. 10.1007/s11904-020-00502-5
    1. Haberer JE, Musiimenta A, Atukunda EC, Musinguzi N, Wyatt MA, Ware NC, et al. . Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids. (2016) 30:1295–300. 10.1097/QAD.0000000000001021
    1. Linnemayr S, Stecher C, Mukasa B. Behavioral economic incentives to improve adherence to antiretroviral medication. Aids. (2017) 31:719–26. 10.1097/QAD.0000000000001387
    1. Bien-Gund CH, Ho JI, Bair EF, Marcus N, Choi RJ, Szep Z, et al. . Brief report: financial incentives and real-time adherence monitoring to promote daily adherence to HIV treatment and viral suppression among people living with HIV: a pilot study. J Acquir Immune Defic Syndr. (2021) 87:688–92. 10.1097/QAI.0000000000002628
    1. Orrell C, Cohen K, Mauff K, Bangsberg DR, Maartens G, Wood R, et al. . Randomized controlled trial of real-time electronic adherence monitoring with text message dosing reminders in people starting first-line antiretroviral therapy. J Acquir Immune Defic Syndr. (2015) 70:495–502. 10.1097/QAI.0000000000000770
    1. Sabin L, DeSilva MB, Gill CJ, Zhong L, Vian T, Xie W, et al. . Improving adherence to antiretroviral therapy with triggered real-time text message reminders: the china adherence through technology study. J Acquir Immune Defic Syndr. (2015) 69:551–9. 10.1097/QAI.0000000000000651
    1. Stringer KL, Azuero A, Ott C, Psaros C, Jagielski CH, Safren SA, et al. . Feasibility and acceptability of real-time antiretroviral adherence monitoring among depressed women living with hiv in the deep South of the US. AIDS Behav. (2019) 23:1306–14. 10.1007/s10461-018-2322-z
    1. Bauer MS, Damschroder L, Hagedorn H, Smith J, Kilbourne AM. An introduction to implementation science for the non-specialist. BMC Psychology. (2015) 3:32. 10.1186/s40359-015-0089-9
    1. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. (2009) 4:50. 10.1186/1748-5908-4-50
    1. Haberer JE, Garrison L, Tumuhairwe JB, Baijuka R, Tindimwebwa E, Tinkamanyire J, et al. . Factors affecting the implementation of electronic antiretroviral therapy adherence monitoring and associated interventions for routine HIV care in Uganda: qualitative study. J Med Internet Res. (2020) 22:e18038. 10.2196/18038
    1. Coetzee B, Kagee A. The development of an inventory to assess the structural barriers to clinic attendance and pill-taking amongst users of antiretroviral therapy. AIDS Behav. (2013) 17:319–28. 10.1007/s10461-012-0374-z
    1. Tsai AC, Bangsberg DR, Emenyonu N, Senkungu JK, Martin JN, Weiser SD. The social context of food insecurity among persons living with HIV/AIDS in rural Uganda. Soc Sci Med. (2011) 73:1717–24. 10.1016/j.socscimed.2011.09.026
    1. Monahan PO Shacham E Reece M Kroenke K Ong'or WO Omollo O . Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in Western Kenya. J Gen Intern Med. (2009) 24:189–97. 10.1007/s11606-008-0846-z
    1. Cherpitel CJ, Ye Y, Bond J, Borges G, Cremonte M, Marais S, et al. . Cross-national performance of the RAPS4/RAPS4-QF for tolerance and heavy drinking: data from 13 countries. J Stud Alcohol. (2005) 66:428–32. 10.15288/jsa.2005.66.428
    1. Babikako HM, Neuhauser D, Katamba A, Mupere E. Patient satisfaction, feasibility and reliability of satisfaction questionnaire among patients with pulmonary tuberculosis in urban Uganda: a cross-sectional study. Health Res Policy Syst. (2011) 9:6. 10.1186/1478-4505-9-6
    1. Jeyaseelan L, Kumar S, Mohanraj R, Rebekah G, Rao D, Manhart LE. Assessing HIV/AIDS stigma in south India: validation and abridgement of the Berger HIV Stigma scale. AIDS Behav. (2013) 17:434–43. 10.1007/s10461-011-0128-3
    1. Ministry of Health. Consolidated Guidelines for Prevention and Treatment of HIV in Uganda. Kampala (2020). Available online at: . (accessed July 6, 2022).
    1. Patton MQ. Qualitative Research and Evaluation Methods. 4th ed. Los Angeles: SAGE Publications, Inc. (2015).
    1. Oleribe OO, Momoh J, Uzochukwu BS, Mbofana F, Adebiyi A, Barbera T, et al. . Identifying key challenges facing healthcare systems in Africa and potential solutions. Int J Gen Med. (2019) 12:395–403. 10.2147/IJGM.S223882
    1. Barker C, Dutta A, Klein K. Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa. J Int AIDS Soc. (2017) 20:21648. 10.7448/IAS.20.5.21648
    1. Thomas BE, Kumar JV, Onongaya C, Bhatt SN, Galivanche A, Periyasamy M, et al. . Explaining differences in the acceptability of 99DOTS, a cell phone-based strategy for monitoring adherence to tuberculosis medications: qualitative study of patients and health care providers. JMIR Mhealth Uhealth. (2020) 8:e16634. 10.2196/16634
    1. Haberer JE, Musinguzi N, Boum Y 2nd, Siedner MJ, Mocello AR, Hunt PW, et al. . Duration of antiretroviral therapy adherence interruption is associated with risk of virologic rebound as determined by real-time adherence monitoring in rural Uganda. J Acquir Immune Defic Syndr. (2015) 70:386–92. 10.1097/QAI.0000000000000737
    1. Phillips AN, Cambiano V, Nakagawa F, Bansi-Matharu L, Sow PS, Ehrenkranz P, et al. . Cost effectiveness of potential ART adherence monitoring interventions in sub-Saharan Africa. PLoS ONE. (2016) 11:e0167654. 10.1371/journal.pone.0167654

Source: PubMed

3
Abonnere